Brief: Arcutis Announces Pricing Of $150 Million Public Offering
Feb 28 (Reuters) - Arcutis Biotherapeutics Inc ARQT.O :
* ARCUTIS ANNOUNCES PRICING OF $150 MILLION PUBLIC OFFERING
* ARCUTIS BIOTHERAPEUTICS - PRICING OF 15.8 MILLION SHARES
OF
COMMON STOCK AT A PUBLIC OFFERING PRICE OF $9.50 PER SHARE
Source text for Eikon: ID:nGNX3Nmw29
Further company coverage: ARQT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arcutis Biotherapeutics
See all newsBrief: Arcutis Canada Przoryve Cream 0.05% Receives Health Canada Approval For Atopic Dermatitis
Arcutis Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Arcutis Q2 revenue rises on demand for ZORYVE, lifts 2026 sales outlook
Arcutis Biotherapeutics Inc expected to post earnings of 4 cents a share - Earnings Preview
Brief: Arcutis Biotherapeutics reports inducement grants under Nasdaq listing rule 5635(C)(4